Gefitinib in Treating Children With Refractory Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of gefitinib in treating children who have
refractory solid tumors. Gefitinib may stop the growth of cancer cells by blocking the
enzymes necessary for tumor cell growth